On June 10, Anlan Medical (China) Co., Ltd. invested and established by Wanbond Group in South Africa officially acquired two well-known medical device companies in South Africa, Tmike and Ailit, at the Gallagher Exhibition Center in Johannesburg, South Africa. The official handover ceremony and press conference were held. The total transaction value of the acquisition is 264 million rand, equivalent to more than 120 million yuan. Yu Yong, Counselor of the Chinese Embassy in South Africa, Zhao Shouming, Chairman, Gao Jian, Co-Chairman of Anlan Securities, John Otto, General Manager of South Africa's Erlit Company, William Skyes, General Manager of Temac, and the medical industry in South Africa Colleagues attended the handover ceremony and press conference.

The two medical device companies in this acquisition are international companies facing the world. Among them, Erlite is a manufacturer of implantable artificial orthopaedic products with strong R&D strength. Athletics. Techmac is one of the enterprises with comprehensive "turnkey" engineering capabilities in medical equipment sales, medical engineering services and overall hospital design, from the procurement, installation and maintenance of a full set of equipment, to the development of hospital management systems and technical training for doctors. .

According to the strategic thinking of Wanbangde Group's "big health industry" globalization layout, the group has started to enter the medical device industry since last year. This time, through the acquisition of the equity of Tekek and Ailite and the investment in follow-up projects, the adjustment of the industrial structure will be accelerated, and the transformation and upgrading of the company will be promoted. Zhao Shouming, chairman of the group, said that this acquisition is the beginning of Wanbangde Group's investment in the big health industry in Africa. This acquisition not only makes up for the company's shortcomings in research and development, but also uses South Africa as a bridgehead to make good use of China's manufacturing capabilities and Capital strength, export more medicines and medical device products to underserved Africa.

In order to industrialize the technology of Ai Lit and Temac, Wanbonde Group also acquired two domestic enterprises specializing in the production of medical devices. Zhao Shouming, chairman of the group, said that building the largest orthopaedic device production base in Asia is one of the goals of Wanbangde Group in the future. It will give full play to the advantages of pharmaceutical and medical device research and development, go hand in hand with the pharmaceutical industry, and vigorously develop the international and domestic markets.

The success of Wanbonde Group in acquiring two well-known medical enterprises in South Africa indicates that Wanbonde Group is going abroad at a steady pace, facing the world, and officially entering the ranks of multinational group companies, thereby gradually expanding into the fields of pharmaceuticals, hospitals, equipment and other fields. In-depth, open the group's big health industry development strategy.

Chairman Zhao Shouming acquired South Africa's Tekek and Ailit

Chairman Zhao Shouming answers reporters' questions